News & Articles

Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development

Two European leaders in biopharma and integrative software are working together to advance drug discovery

Discover how AFABILITY founder Dr. Alison Gray is enabling the transition from animal-derived to non-animal-derived antibodies

Improved assay reduces time to product release by detecting bacteria faster

Join us Wednesday, November 18, to discover the impact metal interactions have on oligo analysis

Addition of CRISPR and RNAi offerings to complement PerkinElmer's life sciences and applied genomics solutions, with future opportunities to improve cell based discovery for precision medicine

This project aims to produce an antiviral and antifouling coating which can be used on PPE to protect staff working in healthcare settings

The StarBright Blue 700, StarBright Violet 440 and StarBright Violet 610 dyes aim to offer maximal brightness for improved resolution

To expand Minimally Invasive Surgery field by reinforcing its orthopedics business

Study by University of Manchester reassures patients that it is safe to take blood pressure medication during the pandemic

Which new products made the most difference to your lab work this year?

New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s

The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance

Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies

The collaboration will focus on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy

Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days

Roche and Atea partner to jointly develop AT-527, an orally administered direct-acting antiviral (DAA) currently in Phase 2 clinical trials

The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts

The company aims to meet the increased demand for approved media to maintain virus viability from sample collection to the lab

The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens

Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry

The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C